Genetic forms of neurodegenerative disorders can help us to define the pathways associated with cellular dysfunction and damage. We are currently using dominant mutations to model cellular damage in Parkinson's disease (PD), dystonia and amyotrophic lateral sclerosis (ALS). Increasingly, we are also focusing on recessive genes that produce overlapping phenotypes to the dominant mutations. The concept is to understand the molecular links between different genes that cause the same disease, and thus to delineate the pathways that underlie neuronal dysfunction and cell death. In PD, where most of the work has been focused, we have shown that mutant alpha-synuclein causes neuronal death and that there is selectivity in these effects. Neurons that use express a dopaminergic neurotransmitter are selectively vulnerable to mutant alpha-synuclein, at least within the cell population cultured from the midbrain. Furthermore, we found that the recessive gene product Parkin can reverse this damage and we have implicated the ubiquitin-proteasome system in this relationship. Using gene-expression profiling, we have identified neurotransmitter alterations in aalpha-synuclein cell lines. We have also collaborated on a number of studies where new PD mutations have been identified, for example in the alpha-synuclein binding protein synphilin-1. More recently, we have begun working on an additional recently discovered recessive PD gene, DJ-1. We have already identified how a point mutation in DJ-1 causes disease; by altering conformation of an alpha-helix near the C-terminus, the protein is greatly destabilized. The challenge now is to understand the cellular function of the normal DJ-1 protein and develop models for loss of this function within the nervous system. Furthermore, whether DJ-1 has any interactions with parkin or alpha-synuclein is under investigation. Work on other diseases has also continued. Some observations of gene expression changes caused by dominant TorsinA mutations have been published, and more extensive work on these mutations is in preparation. We have shown that a recently reported mutation in TorsinA does not have the same cellular effects as a more common, previously reported deletion and have shown that the heat shock protein system is affected by expression of torsinA in vitro. Work on ALS has continued with a proteomics analysis of SOD1 mutations now published; we are currently applying similar approaches to PD models.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Intramural Research (Z01)
Project #
1Z01AG000953-02
Application #
6815508
Study Section
(LNG)
Project Start
Project End
Budget Start
Budget End
Support Year
2
Fiscal Year
2003
Total Cost
Indirect Cost
Name
Aging
Department
Type
DUNS #
City
State
Country
United States
Zip Code
Bisaglia, Marco; Greggio, Elisa; Maric, Dragan et al. (2010) Alpha-synuclein overexpression increases dopamine toxicity in BE2-M17 cells. BMC Neurosci 11:41
Dehvari, Nodi; Sandebring, Anna; Flores-Morales, Amilcar et al. (2009) Parkin-mediated ubiquitination regulates phospholipase C-gamma1. J Cell Mol Med 13:3061-8
Saha, Shamol; Guillily, Maria D; Ferree, Andrew et al. (2009) LRRK2 modulates vulnerability to mitochondrial dysfunction in Caenorhabditis elegans. J Neurosci 29:9210-8
Mortiboys, Heather; Thomas, Kelly Jean; Koopman, Werner J H et al. (2008) Mitochondrial function and morphology are impaired in parkin-mutant fibroblasts. Ann Neurol 64:555-65
van der Brug, Marcel P; Blackinton, Jeff; Chandran, Jayanth et al. (2008) RNA binding activity of the recessive parkinsonism protein DJ-1 supports involvement in multiple cellular pathways. Proc Natl Acad Sci U S A 105:10244-9
Cookson, Mark R; van der Brug, Marcel (2008) Cell systems and the toxic mechanism(s) of alpha-synuclein. Exp Neurol 209:5-11
Greggio, Elisa; Lewis, Patrick A; van der Brug, Marcel P et al. (2007) Mutations in LRRK2/dardarin associated with Parkinson disease are more toxic than equivalent mutations in the homologous kinase LRRK1. J Neurochem 102:93-102
van de Leemput, Joyce; Chandran, Jayanth; Knight, Melanie A et al. (2007) Deletion at ITPR1 underlies ataxia in mice and spinocerebellar ataxia 15 in humans. PLoS Genet 3:e108
Lewis, Patrick A; Greggio, Elisa; Beilina, Alexandra et al. (2007) The R1441C mutation of LRRK2 disrupts GTP hydrolysis. Biochem Biophys Res Commun 357:668-71
Betarbet, Ranjita; Canet-Aviles, Rosa M; Sherer, Todd B et al. (2006) Intersecting pathways to neurodegeneration in Parkinson's disease: effects of the pesticide rotenone on DJ-1, alpha-synuclein, and the ubiquitin-proteasome system. Neurobiol Dis 22:404-20

Showing the most recent 10 out of 62 publications